NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s12026-024-09536-y
Published Online: 2024-09-05
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ali, Awais https://orcid.org/0000-0002-4514-9509
Alamri, Abdulaziz
Hajar, Azraida
Text and Data Mining valid from 2024-09-05
Version of Record valid from 2024-09-05
Article History
Received: 14 June 2024
Accepted: 29 August 2024
First Online: 5 September 2024
Declarations
:
: The authors declare no competing interests.